6
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Pseudotumor cerebri Longitudinal study using contrast sensitivity and automated static perimetry

, &
Pages 97-108 | Accepted 02 Jan 1990, Published online: 08 Jul 2009
 

Abstract

The visual function of 13 patients with pseudotumor cerebri (P.C.) was investigated with a test battery including color vision, V.E.P.s, contrast sensitivity (C.S.) and automated static perimetry (A.S.P.).

C.S. and A.S.P. were both undertaken on a Vision R Monitor System. Ten patients were evaluated since the beginning of the papilledema (group I), three after resolution of papilledema (group II). The color vision test was of poor sensitivity. V.E.P.s were normal. In the acute phase, C.S. was altered in 70% of cases. The enlargement of the blind spot was constant and a visual field defect was found in 60% of cases. The changes of the fundus, C.S. and A.S.P. followed the development of papilledema and improved with it. After resolution of papilledema persistent alterations of fundus and A.S.P. were often associated.

C.S. seems to be a more independent parameter, which normalizes most easily but which has not a predictive value for the final visual outcome. For the diagnosis and the pathogenic study, the fundus examination and A.S.P. are the most useful parameters. C.S. may be used as index of surveillance but further studies are necessary.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.